Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|June 29, 2020
ABO incompatibile graft management in pediatric transplantationAdriana Balduzzi, Halvard Bönig, Andrea Jarisch, et al.
Haematologica|August 18, 2025
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM TrialAdriana Balduzzi, Evgenia Glogova, Christina Peters, et al.
Blood Cancer Discovery|January 12, 2022
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic LeukemiaMichael A Pulsipher, Xia Han, Shannon L Maude, et al.
Cancer Medicine|May 27, 2016
Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007Kerstin Bartelheim, Karolina Nemes, Angela Seeringer, et al.
Human Mutation|December 19, 2009
Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduriaMartijn Kranendijk, Eduard A Struys, K Michael Gibson, et al.
Clinical Epigenetics|October 4, 2025
Epigenetic risk stratification in juvenile myelomonocytic leukemia by targeted methylation analysis of the BMP4 locusFoued Ghanjati, Annika Heck, Dirk Lebrecht, et al.
Blood Advances|January 20, 2026
Comparable outcomes of HSCT upfront and after failure of IST in pediatric aplastic anemia in recent yearsFelicia Andresen, Ayami Yoshimi, Peter Bader, et al.
Blood Advances|March 4, 2026
Refining Busulfan Exposure Enhances Pediatric ALL HSCT Outcomes: Insights from the International FORUM StudyKhalil Ben Hassine, Yvonne Sylvia Gloor, Isabelle Dupanloup, et al.
Blood|November 19, 2025
Outcome of children with B-cell acute lymphoblastic leukemia with hypodiploidy or BCR::ABL1 fusion undergoing allogeneic HSCTJochen Buechner, Ulrike Poetschger, Peter Bader, et al.
The Lancet. Oncology|October 14, 2019
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trialTheodore W Laetsch, Gary Douglas Myers, André Baruchel, et al.
Pageof 9